Modular Medical gets FDA clearance for MODD1 insulin pump; launch expected early 2025

Modular Medical, Inc.

FDA cleared the MODD1 patch pump for all adults with Type 1 and Type 2 diabetes.
Pump designed to be simpler and more affordable to expand access to underserved diabetes communities.
Commercial availability expected in early 2025; manufacturing infrastructure substantially established.
Company plans a conference call to discuss clearance and next steps (details TBA).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.